Evidence map›Paper›PMID 40660985›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2025

[Dynamic changes of HBsAb and its predictive value in patients with chronic hepatitis B receiving antiviral therapy for clinical cure].

H Y Yang, K Y Hao, X E Liang, Z H Liu, C X Zhong, J H Yin, Y Xu, L Y Wu, Y C Yu, J L Hou and 1 more

Abstract readMulticenter StudyEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Sounding the call for functional cure of hepatitis B and opening a new era of combination therapy].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

H Y YangLiver Disease Center and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
K Y HaoLiver Disease Treatment Center, Department of Infectious Diseases, Qinhuai Medical District, Eastern Theater Command General Hospital, Nanjing 210002, China.
X E LiangLiver Disease Center and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Z H LiuLiver Disease Center and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
C X ZhongLiver Disease Center and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
J H YinLiver Disease Center and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Y XuLiver Disease Center and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
L Y WuLiver Disease Center and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Y C YuLiver Disease Treatment Center, Department of Infectious Diseases, Qinhuai Medical District, Eastern Theater Command General Hospital, Nanjing 210002, China.
J L HouLiver Disease Center and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
R FanLiver Disease Center and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

Funding

National Key Research and Development Program 2022YFC2303600
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsHepatitis B AntibodiesHepatitis B, ChronicHepatitis B Surface AntigensAdolescentAdultFemaleHumansMaleMiddle AgedPredictive Value of TestsProspective StudiesYoung AdultAntiviral AgentsHepatitis B AntibodiesHepatitis B Surface Antigens

Identifiers

PMID40660985
PMCPMC12861771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.